BAGSVAERD, DENMARK--(Marketwire - November 07, 2008) - Major shareholder notification- In accordance with Section 29 of the Securities Trading Act, Novo Nordisk hereby reports that on 4 November 2008 Novo Nordisk received notification from The Capital Group Companies Inc. that it pursuant to letter of application of 7 February 2008 to the Danish FSA regarding the exemption requirements for parent companies under Executive Order 1225 section 12 and 14 no longer will report interest in securities in Denmark on its own behalf. Instead, voting interest and ownership in shares will be reported separately by Capital Research and Management Company, Capital Group International Inc. or the mutual funds and clients themselves, as appropriate. None of the individual entities have shareholdings above the threshold of 5% of the issued share capital.
